Chemomab Therapeutics Ltd.

CMMB

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001534248

SEC filings (opens in a new tab)

In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Chemomab Therapeutics Ltd. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of CMMB: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	13	11	−2
Shares	2.89M	2.53M	−358.6K (−12.4%)
Value	$4.56M	$3.33M	−$1.23M (−27.0%)

New holders (1)

Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CMMB in Q2 2023
Institution	Shares	Value	% of portfolio
Rhumbline Advisers	3,005	$3.94K	0.00%

Sold out (3)

Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CMMB in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Cormorant Asset Management, LP	288,169	$458.0K
Two Sigma Investments, LP	30,263	$48.1K
Two Sigma Advisers, LP	11,800	$18.8K